Literature DB >> 9070862

The murine Dyrk protein maps to chromosome 16, localizes to the nucleus, and can form multimers.

W J Song1, S H Chung, D M Kurnit.   

Abstract

We mapped the murine copy of the Dyrk gene and examined its subcellular localization and self-interaction. We found that: (1) Dyrk maps to the distal portion of MMU chromosome 16, consistent with previous mapping of the human DYRK gene to the Down syndrome critical region on HSA 21q22.2. (2) The Dyrk protein localizes to the cell nucleus, affording the potential of controlling the expression of other gene(s). (3) The Dyrk protein can self-associate in a two-hybrid system, in accord with the presence of a leucine zipper motif noted in the original sequence. In particular, its expression pattern in frontal brain nuclei during murine embryogenesis, its subcellular localization and its ability to interact with other proteins all suggest that this protein remains a good candidate to mediate some of the pleiotropic effects of Down syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070862     DOI: 10.1006/bbrc.1997.6154

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A.

Authors:  S Himpel; P Panzer; K Eirmbter; H Czajkowska; M Sayed; L C Packman; T Blundell; H Kentrup; J Grötzinger; H G Joost; W Becker
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

2.  DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras, B-Raf, and MEK1.

Authors:  Paul A Kelly; Zohra Rahmani
Journal:  Mol Biol Cell       Date:  2005-05-25       Impact factor: 4.138

3.  Characterization of Caenorhabditis elegans homologs of the Down syndrome candidate gene DYRK1A.

Authors:  William B Raich; Celine Moorman; Clay O Lacefield; Jonah Lehrer; Dusan Bartsch; Ronald H A Plasterk; Eric R Kandel; Oliver Hobert
Journal:  Genetics       Date:  2003-02       Impact factor: 4.562

4.  Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A).

Authors:  Wojciech Kaczmarski; Madhabi Barua; Bozena Mazur-Kolecka; Janusz Frackowiak; Wieslaw Dowjat; Pankaj Mehta; David Bolton; Yu-Wen Hwang; Ausma Rabe; Giorgio Albertini; Jerzy Wegiel
Journal:  J Neurosci Res       Date:  2013-11-22       Impact factor: 4.164

5.  Activation of androgen receptor function by a novel nuclear protein kinase.

Authors:  A M Moilanen; U Karvonen; H Poukka; O A Jänne; J J Palvimo
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

6.  Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4.

Authors:  Jan Hendrik Sitz; Marcel Tigges; Karsten Baumgärtel; Leonid G Khaspekov; Beat Lutz
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  Physical and comparative mapping of distal mouse chromosome 16. 5 p5.

Authors:  D E Cabin; J W McKee-Johnson; L E Matesic; T Wiltshire; E E Rue; A E Mjaatvedt; Y K Huo; J R Korenberg; R H Reeves
Journal:  Genome Res       Date:  1998-09       Impact factor: 9.043

8.  Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice.

Authors:  Vassiliki Fotaki; Mara Dierssen; Soledad Alcántara; Salvador Martínez; Eulàlia Martí; Caty Casas; Joana Visa; Eduardo Soriano; Xavier Estivill; Maria L Arbonés
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

9.  Systematic Functional Characterization of Human 21st Chromosome Orthologs in Caenorhabditis elegans.

Authors:  Sarah K Nordquist; Sofia R Smith; Jonathan T Pierce
Journal:  G3 (Bethesda)       Date:  2018-03-02       Impact factor: 3.154

10.  The Dual-Specificity Kinase DYRK1A Modulates the Levels of Cyclin L2 To Control HIV Replication in Macrophages.

Authors:  Javan K Kisaka; Lee Ratner; George B Kyei
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.